TipRanks
Go Ultimate55% OFF

NeuroPace (NPCE) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Rns SystemSeizures, Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable, Seizures, GeneralizedPhase IIRecruitingRNS System LGS Feasibility StudyMar 29, 2022―
Responsive Stimulation, Sham StimulationEpilepsy, Idiopathic Generalized Epilepsy, Generalized Tonic Clonic SeizurePhase IIIActive Not RecruitingRNS System NAUTILUS StudyNov 23, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Neuropace, Inc. (NPCE) have in its pipeline
NeuroPace NPCE is currently developing the following drugs: Rns System, Responsive Stimulation, Sham Stimulation. These drug candidates are in various stages of clinical development as the company works toward FDA approval.